November 09, 2023
Danielle Sword | PhD student within the CAR T-cell programme
Posted On November 9, 2023
0
New Zealand’s first trial of a ground-breaking cancer treatment called CAR T-cell therapy has shown the promise of being safer than leading commercial CAR T-cell products in treating certain types of blood cancer, while remaining effective.
New Zealand’s first trial of a ground-breaking cancer treatment called CAR T-cell therapy has shown the promise of being safer than leading commercial CAR T-cell products in treating certain types of blood cancer, while remaining effective.